Lack of Knowledge Versus

References

• Magill TP Francis T Jr. Antigenic differences in strains of human influenza virus Proc Soc Exp Bioi 35 463 - 466 1936
   Google Scholar
• Coleman MT Dowdle WR Pereira HG The Hong Kong/68 influenza A2 variants Lancet 2 1968 1384–1386
   Google Scholar
• Francis T Jr Davenport FM Hennessy AV A serologic recapitulation of human infection with different strains of influenza virus Trans Assoc Arner Physicians 66 231 238 1953
   PubMedGoogle Scholar
• Mulder J Masurel N Pre-epidemic –antibody against the strain of Asiatic influenza in the selum of older persons living in the Netherlands Lancet 1957 1 810 814 1958
   Google Scholar
• Davenport FM Hennessy AV The clinical epidemiology of Asian influenza Ann Intern Med 49 493 501 1958
   Google Scholar
• Masurel N Relation between Hong Kong virus and former human A2 isolates and the A/Equi/2 virus in human sera collected before Lancet 1957
   Google Scholar
• Shope RE Swine influenza: III. Filtration experiments and etiology J Exp Med 54 373 385 1931
   PubMedGoogle Scholar
• Pereira HG ’Lang G OIesiuk OM New antigenic variants of avian influenza A viruses Bull WHO 1966 35 799 802
   PubMedGoogle Scholar
• Kasel JA Alford RH Knight V Experimental infection of human volunteers with equine influenza virus Nature 1965 206 41 43
   Google Scholar
• Alford RH Kasel JA Lehrich JR Human responses to experimental infection with influenza A/Equi/2 virus Amer J Epidem 86 1967 185 192
   Google Scholar
• Sigel MM Kitts AW Light AB The recurrence of influenza A prime in a boarding school after two years J Immun 64 1950 33 38
   Google Scholar
• Pickles WN Burnet FM McArthur N Epidemic respiratory infection in a rural population with special reference to the influenza A epidemics of J Hyg 45 1933 469 473 1936 to 1937, and 1943 to 1944,1947
   Google Scholar
• McDonald JC Zuckerman AJ Beare AS Trials of live influenza vaccine in the Royal Air Force A report to the Medical Research Council Committee on Influenza and other respiratory virus vaccines Brit M J 1 1962 1036–1042
   Google Scholar
• Andrewes BE Beare AS McDonald JC Further trials of live influenza vaccine Brit M J 1 1966 637 640
   Google Scholar
• Morris JA Kasel JA Saglam M Immunity to influenza as related to antibody levels New Eng J Med 274 1966 527 535
   PubMedGoogle Scholar
• Beare AS Tyrrell DAJ Hobson D Live influenza B vaccine in volunteers: A report to the Medical Research Council by their Committee on
   Google Scholar
• Beare AS Hobson D Reed SE A comparison of live and killed influenza-virus vaccines Lancet 1968 2 418 420
   Google Scholar
• Francis T Jr. The inactivation of epidemic influenza virus by nasal secretions of human individuals Science 1940 90 198 199
   Google Scholar
• Francis T Jr. Brightman IJ Virus-inactivating capacity of nasal secretions in the acute and convalescent stages of influenza Proc Soc Exp Biol 48 1941 116 117
   Google Scholar
• Mann JJ Waldman RH Togo Y Antibody response in respiratory secretions of vol unteers given live and dead influenz’a virus
   Google Scholar
• Smith CB Purcell RH Bellanti J A Protective effect of antibody to parainfluenza type 1 virus New Eng J Med 275 1966 1145 1152
   PubMed Web of Science ®Google Scholar
• Downie J Stuart-Harris CH The production of neutralizing activity in serum and nasal secretion following inlmunization with influenza B virus J Hyg 1970 68 507 518
   Google Scholar
• Kilbourne ED Christenson WNll Sande M Antibody response in man to influenza virus neuraminidase following influenza J Virol 2 761 762
   Google Scholar
• Schild GC Newman RW Antibody against influenza A2 virus neuraminidase in human sera J Hyg 1969 67 353 365
   PubMedGoogle Scholar
• Fry J Epidemic influenza: Patterns over 20 years J Roy CoIl Gen Pract 1949 17 100 103
   Google Scholar
• Bashe WJ Jr Stegmiller H Leonida D Failure of polyvalent vaccine to provide clinical protection against Asian influenza New Eng J Med 1964 270 870 874
   Google Scholar
• Maynard JE Dull HE Hanson ML Evaluation of monovalent and polyvalent influenza vaccine during an epidemic of type A2 -and B influenza Amer J Epidem 1968 87 148 157
   Google Scholar
• Hobson D Immunization against respiratory virus infections Cruickshank R Weir DM Modern Trends in Immunology Butterworth & Co Publishers Ltd 2 London 1967 53 85
   Google Scholar
• Tyrrell DAJ Vaccination against respiratory viruses Brit Med Bull 1969 25 165 170
   Google Scholar
• Stuart-Harris CH The prevention of influenza by influenza vaccine Proc Roy Soc M 60 1967 659 662
   Google Scholar
• Commission on Influenza A clinical evaluation of vaccination agaiIlst influenza. JAMA 1944 124 982 985
   Google Scholar
• Davenport FM Present status of inactivated influenza. virus vaccine: First International Conference on Vaccines Against Viral and Rickettsia!
   Google Scholar
• Holland WW Isaacs A Clarke SKR A serological trial of Asian-influenza vaccine after the autumn epidemic Report of Committee on Clinical Trials on Influenza Vaccine to Medical Research Council Lancet Trials of an Asian influenza vaccine Fourth progress 1958 1 820 822
   Google Scholar
• Tyrrell DAJ Studies on vaccination against the A2 Hong Kong virus in J Hyg, 1970,to be published 1968–1969
   Google Scholar
• Davenport FM Hennessy AV Brandon FM Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses of their haemagglutinins J Lab Cun Med 1964 63 5 13
   PubMed Web of Science ®Google Scholar
• Webster RG Laver WG Influenza virus subunit vaccines: Immunogenicity and lack of toxicity for rabbits of ether and detergent disrupted virus J .Immunol 1966 96 596 605
   Google Scholar
• Herbert WJ Multiple emulsions: A new form of mineral-oil antigen adjuvant Lancet 1965 2 771
   Google Scholar
• Taylor PJ Miller CL Pollock TM Antibody response and reactions to aqueous influenza vaccine simple emulsion vaccine and multiple emulsion vaccine A report to the Medical Research Ccouncil Comrrrlttee on Influenza and Other Respiratory Virus Vaccines. J Hyg 67 1969 485 490
   Google Scholar
• Woodhour AF Metzgar DP Sim TB New metabolic immunologic adjuvant for human use: I. Development and animal immune response Proc Soc Exp BioI 1964 116 516 523
   Google Scholar
• Stokes J Jr Weibel RE Woodhour AF New metabolizable immunologic adjuvant for human use: IX. Large-scale trials with multiple lots in different regimens JAMA 1969 207 2067 2072
   Google Scholar
• Pollock TM Report of the Medical Research Council Committee Clinical Trails Influenza Vaccine 1968
   Google Scholar
• Beare AS Bynoe ML Tyrrell DAJ Investigation into the attenuation of influenza viruses by serial passage Brit Med J 1968 4 482 484
   Google Scholar
• Mackenzie JS Virulence of temperature-sensitive mutants of influenza virus Brit M J 3 1969 757 758
   Google Scholar
• Mills J VanKirk J Hill DA Evaluation of influenza virus mutants for possible use in a live virus vaccine: Proceedings of the International Conference on Hong Kong Influenza Bull WHO 1969 41 599 606
   PubMedGoogle Scholar
• Zhdanov VM Present status of live influenza virus vaccines First International Conference on Vaccines Against Viral and Rickettsial Infections in Man Pan American Health Organization Bull WHO 147 1967 9 15
   Google Scholar
• Slepuskin AN Bobyleva TK Russina AE Evaluation of the effectiveness of live influenza vaccine for large-scale vaccination against influenza
   Google Scholar
• Waldman RH Kasel JA Fulk RV Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus Nature 1968 218 594 595
   PubMed Web of Science ®Google Scholar
• Larin NM Beare AS Copping MP Spectrum and characteristics of the virus-inhibitory action of two isoquinoline derivatives Antimicrobial agents and chemotherapy, in Proceedins .of the Seventh I nterscience Conference on Antl, ml crobzal Agents and Chemotherapy Chicago 1967 646 653
   Google Scholar
• Beare AS Bynoe ML Tyrrell DAJ Prophylaxis of influenza with a synthetic isoquinoline Lancet 1 1968 843 845
   Google Scholar
• Sabin AB Amantadine hydrochloride: Analysis of data related to its proposed use for prevention of A2 influenza virus disease in human beings JAMA 1967 200 943 950
   PubMedGoogle Scholar
• Galbraith AW Oxford JS Schild GC Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment Lancet 2 1969 1026 1028
   PubMed Web of Science ®Google Scholar
• Roden AT National experience with Hong Kong influenza in the United Kingdom Bull WHO 1968 41 375 380 1969
   Google Scholar
• Turtle P de Bec Vaccines in the management of influenza epidemics in schools Practitioner 1968 200 254 259
   Google Scholar
• Langmuir AD Henderson DA Serfling RE Epidemiological basis for the control of influenza Ame,. J Public Health 1964 54 563 571
   PubMed Web of Science ®Google Scholar